Voya Financial Advisors, Inc. Gilead Sciences, Inc. Transaction History

Voya Financial Advisors, Inc.

$877 Million
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $24,865 - $35,698	-399 Reduced 9.78%	3,681 $316,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $33,759 - $38,561	567 Added 16.14%	4,080 $257,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $202,770 - $228,380	3,513 New	3,513 $219,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $1.34 Million - $1.47 Million	-21,158 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $48,600 - $55,452	-810 Reduced 3.69%	21,158 $1.39 Million
Q4 2020 Mar 05, 2021	BUY	$56.65 - $64.55 $248,636 - $283,309	4,389 Added 24.97%	21,968 $1.25 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $431,222 - $542,187	6,944 Added 65.29%	17,579 $1.09 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $742,931 - $862,680	-10,270 Reduced 49.13%	10,635 $793,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $33,632 - $43,078	537 Added 2.64%	20,905 $1.59 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $132,113 - $145,320	2,144 Added 11.76%	20,368 $1.32 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $796,814 - $879,543	12,747 Added 232.74%	18,224 $1.15 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $55,806 - $62,580	902 Added 19.72%	5,477 $367,000
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $65,156 - $72,992	-1,042 Reduced 18.55%	4,575 $291,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $107,458 - $140,225	-1,775 Reduced 24.01%	5,617 $348,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $161,377 - $178,674	-2,264 Reduced 23.45%	7,392 $566,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $46,908 - $54,716	-723 Reduced 6.97%	9,656 $679,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $264,991 - $323,054	-3,638 Reduced 25.95%	10,379 $776,000
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $838,502 - $984,283	-11,785 Reduced 45.67%	14,017 $1.02 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.86 Million - $2.21 Million	25,802	25,802 $2.09 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Voya Financial Advisors, Inc. with notifications on news.

Account